See All Slides - tctmd.com

Slides

Presentation TCT 2015

Status Report on Endovascular Aneurysm Sealing (EVAS) With Nellix: Big Promises and a Few Unknowns

Presenter: Clifford J. Buckley, Zvonimir Krajcer

October 15, 2015

Presentation TCT 2015

Access Site and Radiation Exposure: Radial vs Femoral

Presenter: Sanjit S. Jolly, Sunil V. Rao

October 15, 2015

Presentation TCT 2015

PCI vs CABG for LM Disease: New Insights From Syntax LM to Help Choose

Presenter: Davide Capodanno, Gregg W. Stone, Patrick W. Serruys

October 15, 2015

Presentation TCT 2015

Elixir DESolve: Differentiating Features and Latest 150-uM and 100-uM Results

Presenter: Alexandre Abizaid, Pieter C. Smits

October 15, 2015

Presentation TCT 2015

Surgical Approaches and Outcomes to Tricuspid Regurgitation

Presenter: Rebecca T. Hahn, Joachim Schofer, James S. Gammie

October 15, 2015

Presentation TCT 2015

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Douglas W. Losordo

October 15, 2015

Presentation TCT 2015

Left Main PCI vs CABG: Fifteen-Year Results From the Asan Medical Center and 5-Year Results From PRECOMBAT

Presenter: Davide Capodanno, Gregg W. Stone, Jung-Min Ahn

October 15, 2015

Presentation TCT 2015

Intervention for Tricuspid Regurgitation: What Do the Guidelines Say? (ACC/AHA and ESC/EACTS)

Presenter: Rebecca T. Hahn, Joachim Schofer, Alec S. Vahanian

October 15, 2015

Presentation TCT 2015

Pathophysiology and Natural History

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Mark V. Sherrid

October 15, 2015

Presentation TCT 2015

Cangrelor I: Data Essentials From the Champion Trials

Presenter: Deepak L. Bhatt, Robert A. Harrington, Harvey D. White

October 15, 2015

Advertisement

Slides

Status Report on Endovascular Aneurysm Sealing (EVAS) With Nellix: Big Promises and a Few Unknowns

Access Site and Radiation Exposure: Radial vs Femoral

PCI vs CABG for LM Disease: New Insights From Syntax LM to Help Choose

Elixir DESolve: Differentiating Features and Latest 150-uM and 100-uM Results

Surgical Approaches and Outcomes to Tricuspid Regurgitation

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

Left Main PCI vs CABG: Fifteen-Year Results From the Asan Medical Center and 5-Year Results From PRECOMBAT

Intervention for Tricuspid Regurgitation: What Do the Guidelines Say? (ACC/AHA and ESC/EACTS)

Pathophysiology and Natural History

Cangrelor I: Data Essentials From the Champion Trials

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content